Steven Frank Receives Stock Award at Biocryst Pharmaceuticals Inc (BCRX) — SEC Form 4, Sep 02, 2026
SEC Form 4 · No Market Transaction
Stock Award
Compensation grant — no market purchase or sale.
Equity Position
36.7K sh
35,459 → 36,747
Equity Change
+3.6%
shares held after vs before
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Steven Frank CIK 0001583886 |
Director
|
Steven Frank at Biocryst Pharmaceuticals Inc
Full insider history
Bought (12 mo)
—
Sold (12 mo)
—
More from this insider at Biocryst Pharmaceuticals Inc
| 2026-06-15 | Award | — | View |
| 2026-06-02 | Award | — | View |
| 2026-03-03 | Award | — | View |
| 2025-12-02 | Award | — | View |
| 2025-09-03 | Award | — | View |
Non-Derivative Securities Transactions
| Title | Date | Type | Shares | Price | Net Total | Post-Txn | Ownership |
|---|---|---|---|---|---|---|---|
| Common StockF1 | 2026-08-31 | A - Award/Grant | 1,288 A | $9.70 | +$12,494 | 36,747 | Direct |
Footnotes (1)
- F1
- Shares of Common Stock issued to the reporting person in lieu of 100% of the quarterly cash Board Member retainer of $12,500. Show more
Related filings at Biocryst Pharmaceuticals Inc
Institutional Holders
13F holders · Sep 30, 2026
333
institutional managers reporting a position
Largest by reported value
5%+ Holders · 13D/G
4 filers
-
Deerfield Mgmt, L.P. 6.8%
-
Black Rock, Inc. 8.4%
Other insiders at Biocryst Pharmaceuticals Inc
GET /v1/forms/4/0000882796-26-000057
API docs
View Original SEC Filing